Silver Book Fact

Slowing the progression of Parkinson’s disease by just 10% would save $327 million (in direct and indirect costs) to the U.S. annually.

Kurlan R, Clark S, Shoulson I, Penny J. Economic Impact of Protective Therapy for Early Parkinson’s Disease. Ann Neurol. 1988; 24(1): 153

Reference

Title
Economic Impact of Protective Therapy for Early Parkinson’s Disease
Publication
Ann Neurol
Publication Date
1988
Authors
Kurlan R, Clark S, Shoulson I, Penny J
Volume & Issue
Volume 24, Issue 1
Pages
153

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, 21 new medicines are currently in development for the treatment of Parkinson’s disease.  
  • In a study of different treatments for Parkinson’s disease, results showed that the disease can be managed for up to 5 years with a reduces risk of dyskinesia.  
  • The U.S. Food and Drug Administration has approved 5 drugs that have proven to temporarily slow the worsening of Alzheimer’s disease symptoms for an average of 6 – 12 months…  
  • Early Gene Therapy Studies Show Promise for Parkinson’s Disease
     
  • Average Annual Direct Medical Costs Per Person with Parkinson’s Disease